Application of novel maca amine A in preparation of drug for preventing Alzheimer disease
A technology for Alzheimer's disease and macasine, which is applied in the field of pharmaceutical applications, and can solve the problems of no reports of macasine A inhibitory activity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0015] The following examples are in order to specify the substantive technical content of the present invention, and the specific routine details recorded in the following examples cannot limit the protection scope of the present invention.
[0016] 1. Materials and methods
[0017] The Ellman method was used to test the AChE in vitro inhibitory activity. The specific method was as follows: dissolve the drugs to be tested (macacinamine A and positive drug huperzine A, with a purity ≥ 98%) with an appropriate amount of DMSO and add PBS buffer (pH 8.0 ) solution, prepared into mother liquor, and then diluted into different concentrations of drug solutions for subsequent use. During the test, 100 μL of PBS buffer, 20 μL of acetylcholinesterase solution (50 U / L, dissolved in PBS), 20 μL of drug solution (final concentrations of 0.025, 0.05, 0.1, 0.2, 0.4 μg / mL) were sequentially added to the 96-well plate ) and 20 μL of 1.2 mM iodothioacetylcholine (ATCh) as the enzyme reaction ...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com